skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

MAC

(Last updated:11/1/2012; last reviewed:11/1/2012)

MAC
Member Financial Disclosure
Company Relationship
Cohn, David
University of Colorado School of Medicine None N/A
Currier, Judith
University of California, Los Angeles
Achillion DSMB Member
EMD Seronon
Advisory Board
Gilead Consultant
GlaxoSmithKline
Honoraria
Janssen-Cilag
Honoraria, Travel Support
Koronis
DSMB Member
Merck Advisory Board, Research Support
Pfizer Advisory Board
Schering-Plough
Research Support
Tibotec Advisory Support, Research Support, Travel Support
Dorman, Susan
Johns Hopkins University
Bill and Melinda Gates Foundation
Research Support
FDA Research Support
NIH Research Support
Gordin, Fred*
Veterans Affairs Medical Center; Washington , DC
None N/A
Horsburgh, C. Robert
Boston University
Bill and Melinda Gates Foundation
Travel Support
CDC Research Support
Medical Research Council (UK)
Travel Support
NIH Research Support
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.